Literature DB >> 34101481

Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score.

Chi Gao1, Eric C Polley2, Steven N Hart2, Hongyan Huang1, Chunling Hu2, Rohan Gnanaolivu2, Jenna Lilyquist2, Nicholas J Boddicker2, Jie Na2, Christine B Ambrosone3, Paul L Auer4, Leslie Bernstein5, Elizabeth S Burnside6, A Heather Eliassen1,7, Mia M Gaudet8, Christopher Haiman9, David J Hunter1,10, Eric J Jacobs8, Esther M John11, Sara Lindström12,13, Huiyan Ma5, Susan L Neuhausen5, Polly A Newcomb12,13, Katie M O'Brien14, Janet E Olson2, Irene M Ong6, Alpa V Patel8, Julie R Palmer15, Dale P Sandler14, Rulla Tamimi16, Jack A Taylor14, Lauren R Teras8, Amy Trentham-Dietz6, Celine M Vachon2, Clarice R Weinberg14, Song Yao3, Jeffrey N Weitzel5, David E Goldgar17, Susan M Domchek18, Katherine L Nathanson18, Fergus J Couch2, Peter Kraft1.   

Abstract

PURPOSE: This study assessed the joint association of pathogenic variants (PVs) in breast cancer (BC) predisposition genes and polygenic risk scores (PRS) with BC in the general population.
METHODS: A total of 26,798 non-Hispanic white BC cases and 26,127 controls from predominately population-based studies in the Cancer Risk Estimates Related to Susceptibility consortium were evaluated for PVs in BRCA1, BRCA2, ATM, CHEK2, PALB2, BARD1, BRIP1, CDH1, and NF1. PRS based on 105 common variants were created using effect estimates from BC genome-wide association studies; the performance of an overall BC PRS and estrogen receptor-specific PRS were evaluated. The odds of BC based on the PVs and PRS were estimated using penalized logistic regression. The results were combined with age-specific incidence rates to estimate 5-year and lifetime absolute risks of BC across percentiles of PRS by PV status and first-degree family history of BC.
RESULTS: The estimated lifetime risks of BC among general-population noncarriers, based on 10th and 90th percentiles of PRS, were 9.1%-23.9% and 6.7%-18.2% for women with or without first-degree relatives with BC, respectively. Taking PRS into account, more than 95% of BRCA1, BRCA2, and PALB2 carriers had > 20% lifetime risks of BC, whereas, respectively, 52.5% and 69.7% of ATM and CHEK2 carriers without first-degree relatives with BC, and 78.8% and 89.9% of those with a first-degree relative with BC had > 20% risk.
CONCLUSION: PRS facilitates personalization of BC risk among carriers of PVs in predisposition genes. Incorporating PRS into BC risk estimation may help identify > 30% of CHEK2 and nearly half of ATM carriers below the 20% lifetime risk threshold, suggesting the addition of PRS may prevent overscreening and enable more personalized risk management approaches.

Entities:  

Mesh:

Year:  2021        PMID: 34101481      PMCID: PMC8330969          DOI: 10.1200/JCO.20.01992

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   50.717


  45 in total

1.  High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States).

Authors:  Leslie Bernstein; Mark Allen; Hoda Anton-Culver; Dennis Deapen; Pamela L Horn-Ross; David Peel; Richard Pinder; Peggy Reynolds; Jane Sullivan-Halley; Dee West; William Wright; Al Ziogas; Ronald K Ross
Journal:  Cancer Causes Control       Date:  2002-09       Impact factor: 2.506

Review 2.  Germline Genetic Testing for Breast Cancer Risk: The Past, Present, and Future.

Authors:  Siddhartha Yadav; Fergus J Couch
Journal:  Am Soc Clin Oncol Educ Book       Date:  2019-05-17

3.  The lifetime risk of developing breast cancer.

Authors:  E J Feuer; L M Wun; C C Boring; W D Flanders; M J Timmel; T Tong
Journal:  J Natl Cancer Inst       Date:  1993-06-02       Impact factor: 13.506

4.  Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.

Authors:  N Pashayan; S W Duffy; S Chowdhury; T Dent; H Burton; D E Neal; D F Easton; R Eeles; P Pharoah
Journal:  Br J Cancer       Date:  2011-04-05       Impact factor: 7.640

5.  Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Therese B Bevers; Mark Helvie; Ermelinda Bonaccio; Kristine E Calhoun; Mary B Daly; William B Farrar; Judy E Garber; Richard Gray; Caprice C Greenberg; Rachel Greenup; Nora M Hansen; Randall E Harris; Alexandra S Heerdt; Teresa Helsten; Linda Hodgkiss; Tamarya L Hoyt; John G Huff; Lisa Jacobs; Constance Dobbins Lehman; Barbara Monsees; Bethany L Niell; Catherine C Parker; Mark Pearlman; Liane Philpotts; Laura B Shepardson; Mary Lou Smith; Matthew Stein; Lusine Tumyan; Cheryl Williams; Mary Anne Bergman; Rashmi Kumar
Journal:  J Natl Compr Canc Netw       Date:  2018-11       Impact factor: 11.908

Review 6.  Common Genetic Variation and Breast Cancer Risk-Past, Present, and Future.

Authors:  Jenna Lilyquist; Kathryn J Ruddy; Celine M Vachon; Fergus J Couch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-01-30       Impact factor: 4.254

7.  Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.

Authors:  Julie R Palmer; Eric C Polley; Chunling Hu; Esther M John; Christopher Haiman; Steven N Hart; Mia Gaudet; Tuya Pal; Hoda Anton-Culver; Amy Trentham-Dietz; Leslie Bernstein; Christine B Ambrosone; Elisa V Bandera; Kimberly A Bertrand; Traci N Bethea; Chi Gao; Rohan D Gnanaolivu; Hongyan Huang; Kun Y Lee; Loic LeMarchand; Jie Na; Dale P Sandler; Payal D Shah; Siddhartha Yadav; William Yang; Jeffrey N Weitzel; Susan M Domchek; David E Goldgar; Katherine L Nathanson; Peter Kraft; Song Yao; Fergus J Couch
Journal:  J Natl Cancer Inst       Date:  2020-12-14       Impact factor: 13.506

8.  Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.

Authors:  Allison W Kurian; Yun Li; Ann S Hamilton; Kevin C Ward; Sarah T Hawley; Monica Morrow; M Chandler McLeod; Reshma Jagsi; Steven J Katz
Journal:  J Clin Oncol       Date:  2017-04-12       Impact factor: 50.717

9.  Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.

Authors:  Karoline B Kuchenbaecker; Susan L Neuhausen; Mark Robson; Daniel Barrowdale; Lesley McGuffog; Anna Marie Mulligan; Irene L Andrulis; Amanda B Spurdle; Marjanka K Schmidt; Rita K Schmutzler; Christoph Engel; Barbara Wappenschmidt; Heli Nevanlinna; Mads Thomassen; Melissa Southey; Paolo Radice; Susan J Ramus; Susan M Domchek; Katherine L Nathanson; Andrew Lee; Sue Healey; Robert L Nussbaum; Timothy R Rebbeck; Banu K Arun; Paul James; Beth Y Karlan; Jenny Lester; Ilana Cass; Mary Beth Terry; Mary B Daly; David E Goldgar; Saundra S Buys; Ramunas Janavicius; Laima Tihomirova; Nadine Tung; Cecilia M Dorfling; Elizabeth J van Rensburg; Linda Steele; Thomas v O Hansen; Bent Ejlertsen; Anne-Marie Gerdes; Finn C Nielsen; Joe Dennis; Julie Cunningham; Steven Hart; Susan Slager; Ana Osorio; Javier Benitez; Mercedes Duran; Jeffrey N Weitzel; Isaac Tafur; Mary Hander; Paolo Peterlongo; Siranoush Manoukian; Bernard Peissel; Gaia Roversi; Giulietta Scuvera; Bernardo Bonanni; Paolo Mariani; Sara Volorio; Riccardo Dolcetti; Liliana Varesco; Laura Papi; Maria Grazia Tibiletti; Giuseppe Giannini; Florentia Fostira; Irene Konstantopoulou; Judy Garber; Ute Hamann; Alan Donaldson; Carole Brewer; Claire Foo; D Gareth Evans; Debra Frost; Diana Eccles; Fiona Douglas; Angela Brady; Jackie Cook; Marc Tischkowitz; Julian Adlard; Julian Barwell; Kai-ren Ong; Lisa Walker; Louise Izatt; Lucy E Side; M John Kennedy; Mark T Rogers; Mary E Porteous; Patrick J Morrison; Radka Platte; Ros Eeles; Rosemarie Davidson; Shirley Hodgson; Steve Ellis; Andrew K Godwin; Kerstin Rhiem; Alfons Meindl; Nina Ditsch; Norbert Arnold; Hansjoerg Plendl; Dieter Niederacher; Christian Sutter; Doris Steinemann; Nadja Bogdanova-Markov; Karin Kast; Raymonda Varon-Mateeva; Shan Wang-Gohrke; Andrea Gehrig; Birgid Markiefka; Bruno Buecher; Cédrick Lefol; Dominique Stoppa-Lyonnet; Etienne Rouleau; Fabienne Prieur; Francesca Damiola; Laure Barjhoux; Laurence Faivre; Michel Longy; Nicolas Sevenet; Olga M Sinilnikova; Sylvie Mazoyer; Valérie Bonadona; Virginie Caux-Moncoutier; Claudine Isaacs; Tom Van Maerken; Kathleen Claes; Marion Piedmonte; Lesley Andrews; John Hays; Gustavo C Rodriguez; Trinidad Caldes; Miguel de la Hoya; Sofia Khan; Frans B L Hogervorst; Cora M Aalfs; J L de Lange; Hanne E J Meijers-Heijboer; Annemarie H van der Hout; Juul T Wijnen; K E P van Roozendaal; Arjen R Mensenkamp; Ans M W van den Ouweland; Carolien H M van Deurzen; Rob B van der Luijt; Edith Olah; Orland Diez; Conxi Lazaro; Ignacio Blanco; Alex Teulé; Mireia Menendez; Anna Jakubowska; Jan Lubinski; Cezary Cybulski; Jacek Gronwald; Katarzyna Jaworska-Bieniek; Katarzyna Durda; Adalgeir Arason; Christine Maugard; Penny Soucy; Marco Montagna; Simona Agata; Manuel R Teixeira; Curtis Olswold; Noralane Lindor; Vernon S Pankratz; Emily Hallberg; Xianshu Wang; Csilla I Szabo; Joseph Vijai; Lauren Jacobs; Marina Corines; Anne Lincoln; Andreas Berger; Anneliese Fink-Retter; Christian F Singer; Christine Rappaport; Daphne Gschwantler Kaulich; Georg Pfeiler; Muy-Kheng Tea; Catherine M Phelan; Phuong L Mai; Mark H Greene; Gad Rennert; Evgeny N Imyanitov; Gord Glendon; Amanda Ewart Toland; Anders Bojesen; Inge Sokilde Pedersen; Uffe Birk Jensen; Maria A Caligo; Eitan Friedman; Raanan Berger; Yael Laitman; Johanna Rantala; Brita Arver; Niklas Loman; Ake Borg; Hans Ehrencrona; Olufunmilayo I Olopade; Jacques Simard; Douglas F Easton; Georgia Chenevix-Trench; Kenneth Offit; Fergus J Couch; Antonis C Antoniou
Journal:  Breast Cancer Res       Date:  2014-12-31       Impact factor: 6.466

10.  Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.

Authors:  Nilanjan Chatterjee; Montserrat Garcia-Closas; Yan Dora Zhang; Amber N Hurson; Haoyu Zhang; Parichoy Pal Choudhury; Douglas F Easton; Roger L Milne; Jacques Simard; Per Hall; Kyriaki Michailidou; Joe Dennis; Marjanka K Schmidt; Jenny Chang-Claude; Puya Gharahkhani; David Whiteman; Peter T Campbell; Michael Hoffmeister; Mark Jenkins; Ulrike Peters; Li Hsu; Stephen B Gruber; Graham Casey; Stephanie L Schmit; Tracy A O'Mara; Amanda B Spurdle; Deborah J Thompson; Ian Tomlinson; Immaculata De Vivo; Maria Teresa Landi; Matthew H Law; Mark M Iles; Florence Demenais; Rajiv Kumar; Stuart MacGregor; D Timothy Bishop; Sarah V Ward; Melissa L Bondy; Richard Houlston; John K Wiencke; Beatrice Melin; Jill Barnholtz-Sloan; Ben Kinnersley; Margaret R Wrensch; Christopher I Amos; Rayjean J Hung; Paul Brennan; James McKay; Neil E Caporaso; Sonja I Berndt; Brenda M Birmann; Nicola J Camp; Peter Kraft; Nathaniel Rothman; Susan L Slager; Andrew Berchuck; Paul D P Pharoah; Thomas A Sellers; Simon A Gayther; Celeste L Pearce; Ellen L Goode; Joellen M Schildkraut; Kirsten B Moysich; Laufey T Amundadottir; Eric J Jacobs; Alison P Klein; Gloria M Petersen; Harvey A Risch; Rachel Z Stolzenberg-Solomon; Brian M Wolpin; Donghui Li; Rosalind A Eeles; Christopher A Haiman; Zsofia Kote-Jarai; Fredrick R Schumacher; Ali Amin Al Olama; Mark P Purdue; Ghislaine Scelo; Marlene D Dalgaard; Mark H Greene; Tom Grotmol; Peter A Kanetsky; Katherine A McGlynn; Katherine L Nathanson; Clare Turnbull; Fredrik Wiklund; Stephen J Chanock
Journal:  Nat Commun       Date:  2020-07-03       Impact factor: 14.919

View more
  6 in total

Review 1.  AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022.

Authors:  Nina Ditsch; Achim Wöcke; Michael Untch; Christian Jackisch; Ute-Susann Albert; Maggie Banys-Paluchowski; Ingo Bauerfeind; Jens-Uwe Blohmer; Wilfried Budach; Peter Dall; Eva Maria Fallenberg; Peter A Fasching; Tanja N Fehm; Michael Friedrich; Bernd Gerber; Oleg Gluz; Nadia Harbeck; Jörg Heil; Jens Huober; Hans H Kreipe; David Krug; Thorsten Kühn; Sherko Kümmel; Cornelia Kolberg-Liedtke; Sibylle Loibl; Diana Lüftner; Michael Patrick Lux; Nicolai Maass; Christoph Mundhenke; Ulrike Nitz; Tjoung-Won Park-Simon; Toralf Reimer; Kerstin Rhiem; Achim Rody; Marcus Schmidt; Andreas Schneeweiss; Florian Schütz; Hans-Peter Sinn; Christine Solbach; Erich-Franz Solomayer; Elmar Stickeler; Christoph Thomssen; Isabell Witzel; Volkmar Müller; Wolfgang Janni; Marc Thill
Journal:  Breast Care (Basel)       Date:  2022-05-05       Impact factor: 2.268

Review 2.  A roadmap to increase diversity in genomic studies.

Authors:  Segun Fatumo; Tinashe Chikowore; Ananyo Choudhury; Muhammad Ayub; Alicia R Martin; Karoline Kuchenbaecker
Journal:  Nat Med       Date:  2022-02-10       Impact factor: 87.241

Review 3.  Design and user experience testing of a polygenic score report: a qualitative study of prospective users.

Authors:  Deanna G Brockman; Lia Petronio; Jacqueline S Dron; Bum Chul Kwon; Trish Vosburg; Lisa Nip; Andrew Tang; Mary O'Reilly; Niall Lennon; Bang Wong; Kenney Ng; Katherine H Huang; Akl C Fahed; Amit V Khera
Journal:  BMC Med Genomics       Date:  2021-10-01       Impact factor: 3.622

4.  Precise, Genotype-First Breast Cancer Prevention: Experience With Transferring Monogenic Findings From a Population Biobank to the Clinical Setting.

Authors:  Hannes Jürgens; Laura Roht; Liis Leitsalu; Margit Nõukas; Marili Palover; Tiit Nikopensius; Anu Reigo; Mart Kals; Kersti Kallak; Riina Kütner; Kai Budrikas; Saskia Kuusk; Vahur Valvere; Piret Laidre; Kadri Toome; Kadri Rekker; Mikk Tooming; Tiina Kahre; Krista Kruuv-Käo; Katrin Õunap; Peeter Padrik; Andres Metspalu; Tõnu Esko; Krista Fischer; Neeme Tõnisson
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

5.  Management of Women With Breast Cancer and Pathogenic Variants in Genes Other Than BRCA1 or BRCA2.

Authors:  Mark Robson
Journal:  J Clin Oncol       Date:  2021-06-09       Impact factor: 50.717

6.  Risk of Late-Onset Breast Cancer in Genetically Predisposed Women.

Authors:  Nicholas J Boddicker; Chunling Hu; Jeffrey N Weitzel; Peter Kraft; Katherine L Nathanson; David E Goldgar; Jie Na; Hongyan Huang; Rohan D Gnanaolivu; Nicole Larson; Amal Yussuf; Song Yao; Celine M Vachon; Amy Trentham-Dietz; Lauren Teras; Jack A Taylor; Christopher E Scott; Dale P Sandler; Tina Pesaran; Alpa V Patel; Julie R Palmer; Irene M Ong; Janet E Olson; Katie O'Brien; Susan Neuhausen; Elena Martinez; Huiyan Ma; Sara Lindstrom; Loic Le Marchand; Charles Kooperberg; Rachid Karam; David J Hunter; James M Hodge; Christopher Haiman; Mia M Gaudet; Chi Gao; Holly LaDuca; James V Lacey; Jill S Dolinsky; Elizabeth Chao; Brian D Carter; Elizabeth S Burnside; Kimberly A Bertrand; Leslie Bernstein; Paul W Auer; Christine Ambrosone; Siddhartha Yadav; Steven N Hart; Eric C Polley; Susan M Domchek; Fergus J Couch
Journal:  J Clin Oncol       Date:  2021-07-22       Impact factor: 50.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.